Anuh Pharma Limited has submitted a regulatory disclosure to the BSE Limited and the National Stock Exchange of India Limited. The disclosure is made pursuant to Regulation 30 read with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has dispatched letters to shareholders whose email addresses are not registered with the company, its Registrar and Share Transfer Agent (RTA), or their respective Depository Participant(s). This communication provides a web link and navigation path for accessing the Annual Report for the Financial Year 2025-26 on the company's website.
The 66th Annual General Meeting (AGM) of the company is scheduled to be held on Wednesday, 12th August 2026 at 04:00 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The web link provided for the annual report is: https://www.anuhpharma.com/investor-relations/wp-content/uploads/2026/07/APLAR-2025-26Final.pdf
The website navigation path is: www.anuhpharma.com > Investor Relations > Annual Reports > Financial Year 2025 - 2026
The company encourages members to register or update their email IDs with their Depository Participants or Bigshare Services Pvt Ltd at investor@bigshareonline.com to receive all communications electronically. Members holding shares in physical form are requested to consider dematerializing their holdings to ensure compliance with SEBI guidelines.